MDL | MFCD18384977 |
---|---|
Molecular Weight | 439.53 |
Molecular Formula | C26H21N3O2S |
SMILES | O=S(C1=CC=C(C2=NC(C3=CC=NC=C3)=C(C4=CC=C5C=C(OC)C=CC5=C4)N2)C=C1)C |
IC50: 250 nM (Tie2) [1]
Tie2 kinase inhibitor 1 (compound 5) has an IC
50
of 50 μM for p38 and has moderate to excellent cellular activities (cell IC
50
=232 nM)
[1]
.
Tie2 kinase inhibitor 1 inhibits tunica internal endothelial cell kinase 2 (Tie2)
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Tie2 kinase inhibitor 1 (intraperitoneally; 50 mg/kg; twice a week for 6 weeks) results in statistically significant reductions in tumor volume by day 15. Tie2 kinase inhibitor 1 results in a 61% reduction in tumor volume by day 20, and reduces tumor volume by 45% by 6 weeks
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Athymic nude mice (6- to 8-week-old females) [1] |
Dosage: | 50 mg/kg |
Administration: | Intraperitoneally; twice a week for 6 weeks |
Result: | Resulted in statistically significant reductions in tumor volume. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 17.86 mg/mL ( 40.63 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.2752 mL | 11.3758 mL | 22.7516 mL |
5 mM | 0.4550 mL | 2.2752 mL | 4.5503 mL |
10 mM | 0.2275 mL | 1.1376 mL | 2.2752 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 1.79 mg/mL (4.07 mM); Clear solution